No Detail Found!

Interleukin-6 in Patients with Cardiac Myxoma

Author(s)
Shi-Min Yuan Department of Cardiothoracic Surgery, The First Hospital of Putian, Teaching Hospital, Fujian Medical University,Putian, Fujian Province,China
Hui-Zhen Lin Department of Clinical Laboratory, The First Hospital of Putian, Teaching Hospital, Fujian Medical University,Putian, Fujian Province,China
Abstract
The relationships between interleukin (IL)-6 and cardiac myxoma remain to be clari ed. This article systematically reviewed the IL-6 properties in cardiac myxoma patients based on retrieval of pertinent literature published between 1998 and 2018. Signi cant di erences were found in circulating IL-6 values between preoperation and 1 and 6 months after operation. Preoperative circulating IL-6 correlated signi cantly with tumour volume (r=0.8552, p=0.003), while there were no signi cant correlations with maximal tumour dimension (r=0.2443, p=0.190). No correlation was found between circulating IL-6 at 1 and 6 months after tumour resection with either tumour volume or with maximal tumour dimension. The positive rate of immunostaining of IL-6 in cardiac myxoma tissues was 93.3%. Overproduction of IL-6 is responsible for the in ammatory presentations, constitutional symptoms, and recurrence and distal embolisation of cardiac myxoma. Cardiac myxoma could be a cellular source of IL-6 release. Cardiac myxoma resection is an absolute choice of eliminating IL-6 production in these patients.
Publication Details
Page(s) 849-852
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 30, Issue: 8, Year: 2020

Request the full text from PASTIC

Keywords
Interleukin-6, Cytokines, Neoplasms, In ammation, Cardiac surgical procedures
0

Citations

0

Downloads

55

Views